HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.

Author: ChangSandy Y, CoffinierCatherine, FarberEmily A, FongLoren G, HrycynaChristine A, HudonSarah E, YoungStephen G

Paper Details 
Original Abstract of the Article :
HIV protease inhibitors (HIV-PIs) target the HIV aspartyl protease, which cleaves the HIV gag-pol polyprotein into shorter proteins required for the production of new virions. HIV-PIs are a cornerstone of treatment for HIV but have been associated with lipodystrophy and other side effects. In both h...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1948915/

データ提供:米国国立医学図書館(NLM)

HIV Protease Inhibitors: A Double-Edged Sword?

HIV protease inhibitors (HIV-PIs) are crucial for the treatment of HIV infection, but they can also cause side effects. This research investigates a potential mechanism underlying these side effects, specifically focusing on the accumulation of prelamin A, a protein involved in nuclear structure, in response to HIV-PI treatment.

HIV-PIs' Impact on Prelamin A Accumulation

The study found that HIV-PIs inhibited the processing of prelamin A, leading to its accumulation in cells. This accumulation was particularly pronounced in fibroblasts heterozygous for Zmpste24 deficiency, a gene involved in the processing of prelamin A. The authors concluded that HIV-PIs inhibit the enzyme ZMPSTE24, which is responsible for the final step in prelamin A processing, leading to its accumulation. This finding suggests that the inhibition of ZMPSTE24 by HIV-PIs could contribute to the side effects of these drugs.

Understanding the Potential Side Effects of HIV-PIs

This research provides crucial insights into the potential side effects of HIV-PIs, highlighting the importance of understanding their impact on cellular processes. The study's findings suggest that the accumulation of prelamin A in response to HIV-PI treatment might play a role in the development of lipodystrophy and other side effects. Further research is needed to confirm this link and explore strategies to mitigate these side effects.

Dr.Camel's Conclusion

Imagine HIV-PIs as powerful desert winds capable of clearing the path for a healthier life. However, these winds can sometimes carry unexpected sandstorms, in this case, the accumulation of prelamin A. This research sheds light on the potential side effects of these powerful medications, reminding us that even the most effective remedies can have unforeseen consequences. Understanding these complexities is crucial for guiding safe and effective HIV treatment.

Date :
  1. Date Completed 2007-10-24
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

17652517

DOI: Digital Object Identifier

PMC1948915

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.